Reduced ribonucleotide reductase RRM2 subunit expression increases DNA damage and mitochondria dysfunction in woody breast chickens

被引:3
|
作者
Shakeri, Majid [1 ]
Choi, Janghan [1 ]
Harris, Caitlin [1 ]
Buhr, Richard Jeff [1 ]
Kong, Byungwhi [1 ]
Zhuang, Hong [1 ]
Bowker, Brian [1 ]
机构
[1] USDA ARS, US Natl Poultry Res Ctr, Athens, GA 30605 USA
关键词
woody breast; broiler chicken; ribonucleotide reductase enzyme; DNA damage; mitochondria; METABOLISM; LACTATE; DIAGNOSIS; SPARC; CELLS; MEAT;
D O I
10.2460/ajvr.23.12.0283
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
OBJECTIVE The aim of this study was to investigate the roles of ribonucleotide reductase subunit M2 (RRM2; subunit of ribonucleotide reductase) in severe woody breast (WB) and normal breast muscles. ANIMALS 40 8 -week-old male Ross -708 broiler chickens. METHODS Quantitative PCR was performed to determine gene expression, and commercial ELISA/assay kits were used to obtain several enzymatic activities. RESULTS Results showed that RRM2 activity (P = .0002) and RRM2 (P = .05) and hydroxymethylbilane synthase expression (impaired oxygen transport and metabolism, P = .002) were reduced in WB, while caveolin-3 (defected membrane integrity, P = .09), endoglin (increased fibrosis, P = .06), and secreted protein acidic rich in cysteine (metabolic dysregulation, P = .09) expression tended to increase in WB. WB tended to have increased levels of homocysteine (P = .06), aspartate aminotransferase mitochondria (P = .02), pyruvate kinase (P = .04), DNA damage (P = .06), creatine kinase (P = .05), and triglyceride (P = .002) but decreased ATPase activity (P = .01), all indicating mitochondria dysfunction and tissue damage. CLINICAL RELEVANCE In this study, differences in various enzyme activities and increased DNA damage suggest that RRM2-mediated mitochondrial abnormalities may play a role in WB myopathy.
引用
收藏
页数:7
相关论文
共 35 条
  • [21] Ribonucleotide reductase subunit 2 (RRM2) predicts shorter survival in resected stage I-III non-small cell lung cancer (NSCLC) patients
    Grossi, F.
    Rijavec, E.
    Dal Bello, M. G.
    Savarino, G.
    Sini, C.
    Barletta, G.
    Genova, C.
    Truini, M.
    Pfeffer, U.
    Merlo, D. F.
    LUNG CANCER, 2012, 77 : S23 - S23
  • [22] RIBONUCLEOTIDE REDUCTASE SUBUNIT 2 (RRM2) PREDICTS SHORTER SURVIVAL IN RESECTED STAGE I-III NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Grossi, F.
    Barletta, G.
    Sini, C.
    Rijavec, E.
    Genova, C.
    Dal Bello, M. G.
    Savarino, G.
    Truini, M.
    Merlo, F.
    Pronzato, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 79 - 79
  • [23] Ribonucleotide reductase subunit 2 (RRM2) to predict shorter survival in resected stage I-III non-small cell lung cancer (NSCLC) patients.
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Sini, Claudio
    Barletta, Giulia
    Genova, Carlo
    Truini, Mauro
    Pronzato, Paolo
    Merlo, Domenico Franco
    Pfeffer, Ulrich
    Grossi, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage
    Lin, Z. Ping
    Lee, Yashang
    Lin, Fang
    Belcourt, Michael F.
    Li, Peining
    Cory, Joseph G.
    Glazer, Peter M.
    Sartorelli, Alan C.
    MOLECULAR PHARMACOLOGY, 2011, 80 (06) : 1000 - 1012
  • [25] A NOVEL GALLIUM COMPOUND DISRUPTS TUMOR IRON HOMEOSTASIS AND RETARDS THE GROWTH OF GLIOBLASTOMA IN VIVO BY INHIBITING THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE (RRM2)
    Chitambar, Christopher
    Al-Gizawiy, Mona
    Lozen, Andrew
    Pechman, Kimberly
    Wereley, Janine
    Wujek, Robert
    Clark, Paul
    Kuo, John
    Elford, Howard
    Hedlund, Bo
    Joshi, Devashish
    Antholine, William
    Schmainda, Kathleen
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E213 - E213
  • [26] Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2)
    Li, Siwei
    Zhang, Heng
    Jiao, Yunping
    Song, Xiao
    Wei, Lei
    Liu, Xing
    BIOENGINEERED, 2022, 13 (05) : 12912 - 12926
  • [27] Ribonucleotide reductase subunit-2 (RRM2) and thymidylate synthase (TS) to predict shorter survival in patients (pts) with resected stage I-III non-small cell lung cancer (NSCLC)
    Grossi, Francesco
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Salvi, Sandra
    Puzone, Roberto
    Pfeffer, Ulrich
    Fontana, Vincenzo
    Rijavec, Erika
    Genova, Giulia Barletta Carlo
    Sini, Claudio
    Ratto, Giovanni Battista
    Truini, Mauro
    Merlo, Domenico Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] REDUCED EXPRESSION OF PROTEIN PHOSPHATASE 2A SUBUNIT, B55A, IN BREAST CANCER DNA DAMAGE REPAIR PATHWAYS
    Panicker, Nikita
    Watt, Lauren
    Kahl, Richard
    Dun, Matthew
    Greer, Peter
    Skelding, Kathryn
    Verrills, Nicole
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 14 - 14
  • [29] RETRACTION: Retraction notice to <Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer (vol 136 pg 261, 2004) (Retraction of Vol 136, Pg 261, 2004)
    Duxbury, Mark S.
    Ito, Hiromichi
    Benoit, Eric
    Zinner, Michael J.
    Ashley, Stanley W.
    Whang, Edward E.
    SURGERY, 2023, 173 (04) : 1109 - 1109
  • [30] ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage
    Chang, Lufen
    Zhou, Bingsen
    Hul, Shuya
    Guo, Robin
    Liu, Xiyong
    Jones, Stephen N.
    Yen, Yun
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (47) : 18519 - 18524